Samuel Backenroth Vascular Biogenics Ltd. (VBLT) insider trading activity

VBLT Quotes by TradingView

Samuel Backenroth is Chief Financial Officer of Vascular Biogenics Ltd.. Currently has a direct ownership of 525,000 shares of VBLT, which is worth approximately $0. The most recent transaction as insider was on Mar 31, 2023, when has been sold 525,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 525K
0% 3M change
0% 12M change
Total Value Held $0

Samuel Backenroth Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2023
BUY
Exercise of conversion of derivative security
-
525,000 Added 50.0%
525,000 Ordinary Shares

Also insider at

NBSE
NeuBase Therapeutics, Inc. Healthcare
CFO, Treasurer & Secretary
SB

Samuel Backenroth

Chief Financial Officer
Pittsburgh, PA

Track Institutional and Insider Activities on VBLT

Follow Vascular Biogenics Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VBLT shares.

Notify only if

Insider Trading

Get notified when an Vascular Biogenics Ltd. insider buys or sells VBLT shares.

Notify only if

News

Receive news related to Vascular Biogenics Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VBLT